deltatrials
Completed PHASE4 NCT00247052

Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion

the Post Operative Pericardial Effusion (POPE) Treatment Study

Sponsor: CLIPA

Conditions Pericardial Effusion
Interventions diclofenac matching placebo
Updated 6 times since 2017 Last updated: Jul 31, 2009 Started: Mar 31, 2006 Primary completion: Dec 31, 2008 Completion: Feb 28, 2009

Listed as NCT00247052, this PHASE4 trial focuses on Pericardial Effusion and remains completed. Sponsored by CLIPA, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CLIPA
  • Clinact
  • French Cardiology Society
Data source: French Cardiology Society

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bordeaux, France
  • • Briis-sous-Forges, France
  • • Lyon, France
  • • Paris, France
  • • Villeneuve-Saint-Denis, France